Breast implant revision vs exchange vs explant

Breast implant revision is an umbrella term for another operation on an augmented or reconstructed breast. Exchange removes and replaces an implant; explant removes it without automatic replacement. Any pathway may also include partial or total capsule work, pocket repair, lift, reduction, fat grafting, scar revision, tissue sampling, or reconstruction. The complete indication-by-side plan matters more than the headline term.¹²³

“Revision” does not mean the original operation failed, and “explant” does not specify what happens to the capsule or tissue envelope. Start by naming the problem being solved.

One operation can contain several decisions

The consensus terminology reserves en bloc capsulectomy for removal of the implant and capsule with a margin of uninvolved tissue when an oncologic indication exists; it is not a synonym for every explant or intact capsule removal.⁵ The capsulectomy and en-bloc guide explains those boundaries.

Build the indication list side by side

Common revision questions include rupture or deflation, capsular contracture, pain, malposition, bottoming out, symmastia, rippling, asymmetry, infection, seroma, skin or scar concerns, implant preference, breast tissue change, systemic symptoms, or concern about implant-associated malignancy. More than one can coexist, and right and left sides can need different work.

Create a table for each side:

• current implant name, fill, size, profile, surface, serial/lot, date, and plane;
• reason for reoperation and evidence supporting it;
• imaging, fluid, capsule, mass, lymph-node, or pathology findings if relevant;
• planned device disposition;
• capsule and pocket plan;
• breast-tissue, skin, nipple, lift, reduction, or grafting plan;
• specimens for pathology or microbiology; and
• backup plan if operative findings differ.

An implant card and prior operative report can prevent guesswork. If unavailable, ask the prior practice, hospital, or manufacturer registry before assuming device details.

Exchange is not routine maintenance on a calendar

FDA says breast implants are not lifetime devices and that complication and reoperation risk increases with time, but there is no universal automatic ten-year replacement rule.¹ A person may exchange because of rupture, contracture, malposition, tissue change, preference, or another documented reason. The ten-year myth guide separates surveillance from a calendar promise.

For an exchange, ask whether the new implant changes fill, dimensions, profile, surface, manufacturer, pocket plane, and weight on the tissue. A larger or differently shaped device can require pocket work or change long-term tissue stress. A smaller device can reveal excess skin or ptosis that prompts a lift discussion.

Warranty terms are financial contracts, not medical indications. Verify which device costs, surgery, facility, anesthesia, shipping, or eligibility conditions they cover.

Explant leaves an envelope decision

After removal, skin and breast tissue may contract, sag, fold, appear deflated, or remain asymmetric depending on implant size, tissue quality, capsule, breast volume, pregnancy, weight change, radiation, and prior operations. A surgeon may discuss no additional shaping, immediate or staged lift/reduction, fat grafting, replacement, or reconstruction.

Ask for a realistic range rather than a guaranteed appearance. Photos of another person cannot predict how an individual envelope will settle. If a lift is proposed, identify incision pattern, nipple/breast-tissue plan, blood-supply concerns, and whether staging could reduce uncertainty.

Explant is also not one evidence-based cure for every systemic symptom. The 2026 systematic review reports heterogeneous symptom changes after explant/capsule procedures, with varied definitions, selection, procedures, and follow-up.⁴ It supports taking symptoms seriously and documenting outcomes; it does not guarantee resolution or prove one capsule technique is universally necessary.

Capsule work follows an indication and safety plan

Capsule may be left, opened, partially removed, totally removed, or—in specific oncologic surgery—removed en bloc with a tissue margin. The choice depends on findings such as contracture, calcification, rupture contents, infection, fluid, mass, device type, tissue adherence, reconstruction, and surgical risk.

Total or intact removal can add dissection near ribs, muscle, lung, and blood vessels, particularly for posterior capsules. Ask what benefit is expected, what may make complete removal unsafe, how a change in plan is consented, and which specimens go to pathology.

If late swelling, a mass, enlarged nodes, or fluid is present, the diagnostic pathway should precede routine cosmetic framing. Ask how imaging and assessment of fluid or tissue are handled and when specialist referral is used.¹ The implant-associated lymphoma and capsule-SCC guide covers the diagnosis-specific record.

Revision planning needs the original and new device records

FDA patient decision checklists and manufacturer labeling supply device-specific risks, surveillance, and warranty terms. For a new implant, review those materials as a new device decision—not merely a continuation of the first augmentation.

Record the new implant’s approved labeling, dimensions, surface, fill, serial/lot, expiration, and placement. Implant approval does not approve the overall surgical plan or certify the surgeon and facility.

Evidence and photos must disclose the whole operation

A gallery labeled “explant” may include total capsulectomy, lift, reduction, fat grafting, or weight change. An “exchange” may include pocket reinforcement and a different plane. Ask for standardized views, time point, complete procedure, pathology findings, complications, and later revisions.

Outcomes to compare include symptom trajectory where relevant, breast shape, scars, sensation, nipple/breast blood supply, asymmetry, recurrent contracture or malposition, graft take, implant complications, pathology, reoperation, and patient priorities. One satisfaction score cannot substitute for all of them.

Normalize the total quote and contingency

Separate surgeon, assistant, facility, anesthesia, device, capsule/pocket work, lift/reduction, grafting and donor site, mesh or support material, imaging, pathology, drains, garments, medications, overnight care, travel, follow-up, and revision terms.

Ask how the quote changes if rupture, calcification, unexpected adherence, fluid, mass, thin tissue, or device mismatch is discovered. A fixed package can conceal clinically necessary branches.

1. Retrieve the original record Gather implant cards, operative report, serial/lot, plane, incision, prior complications, imaging, and pathology.
2. Name the indication by side Separate device, capsule, pocket, skin, breast tissue, symptoms, preference, and diagnostic findings.
3. Translate the terminology Define revision, exchange, explant, capsulotomy/capsulectomy extent, pocket work, lift, grafting, and staging.
4. Plan for operative findings Consent backup choices for rupture, adherence, fluid, mass, tissue quality, pathology, or inability to perform a planned maneuver safely.
5. Normalize evidence and cost Compare complete operations, patient populations, outcomes, follow-up, every fee, warranties, and revision responsibility.

Write the revision as side-specific actions

Ask: “For each breast, what problem is being solved, what happens to the implant, capsule, pocket, and tissue envelope, and what changes if the operative findings differ?” “Revision,” “exchange,” and “explant” are only the first line of that answer.